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Neuronal overexpression of APPL, the Drosophila homologue of
the amyloid precursor protein (APP), disrupts axonal transport
Laura Torroja, Hsin Chu, Irina Kotovsky and Kalpana White
The two pathological hallmarks of Alzheimer’s disease,
amyloid plaques and neurofibrillary tangles, involve two
apparently unrelated proteins, the amyloid precursor
protein (APP) and Tau. Although it is known that
aberrant processing of APP is associated with
Alzheimer’s disease [1], the definitive role of APP in
neurons is not yet clear [2]. Tau regulates microtubule
stabilization and assembly in axons [3] and is, thus, an
essential component of the microtubule-associated
organelle transport machinery [4,5]. Although several
groups have reported physical interaction between APP
and Tau [6,7], and induction of Tau phosphorylation by
APP [8] and β-amyloid peptide [9], the functional
connection between APP and Tau is unclear. To explore
the possibility that the functions of these two proteins
may somehow converge on the same cellular process,
we overexpressed APPL, the Drosophila homologue of
APP, along with Tau in Drosophila neurons. Panneural
coexpression of APPL and Tau resulted in adults that,
upon eclosion, failed to expand wings and harden the
cuticle, which is suggestive of neuroendocrine
dysfunction. We analyzed axonal transport when Tau
and APPL were coexpressed and found that transport of
axonal cargo was disrupted, as evidenced by increased
retention of synaptic proteins in axons and scarcity of
neuropeptide-containing vesicles in the distal processes
of peptidergic neurons. In an independent approach, we
demonstrated genetic interaction and phenotypic
similarity between APPL overexpression and mutations
in the Kinesin heavy chain (Khc) gene, the product of
which is a motor for anterograde vesicle trafficking [10]. 
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Results and discussion
Overexpression of APPL and Tau in neurons disrupts
microtubule-associated transport
The Appl gene encodes the Drosophila functional homo-
logue of APP [11]. Both loss-of-function Appl mutant flies
and APP knockout mice are viable and show behavioral
deficits without displaying gross morphological defects
[11–13]. Because gain-of-function phenotypes have often
provided important insights into normal cellular functions,
including those for proto-oncogene products [14] and cell
adhesion molecules [15], we overexpressed APPL and
bovine Tau in Drosophila neurons using the Gal4–upstream
activation sequence (UAS) system [16] to investigate
whether the cellular functions of APPL and Tau intersect.
Transgenic flies were generated carrying the UAS–Appl
transgene, with the EcoRI fragment of Appl cDNA s1 [17]
inserted downstream of the Gal4-binding UAS promoter.
The UAS–tau transgene used expresses a bovine Tau con-
taining four microtubule-binding repeats [18], because
although there are proteins with structures and properties
that are analogous to mammalian Tau in Drosophila [19],
the Drosophila tau gene has yet to be cloned. Panneural
targeted expression was achieved with Gal4 drivers
ApplG1a (a partial Appl promoter upstream of Gal4) and
c155 [15]; both drivers express at higher levels in males
due to dosage compensation. 
Coexpression of APPL and Tau resulted in a pronounced
decrease in male viability (37.9% viability in
ApplG1a;UAS–Appl UAS–tau/+ males), with the viability
for males expressing only APPL or only Tau being much
higher (~67% for both ApplG1a;UAS–Appl/+ and
ApplG1a;UAS–tau/+ males). In all cases, lethality occurred
mostly during the pharate adult stage. More notably, the
eclosing adults exhibited an ‘infantile’ phenotype in which
wing expansion and cuticle hardening did not occur.
Almost 100% of the eclosed males coexpressing APPL and
Tau were infantile, whereas only a small, but significant,
fraction of those expressing only APPL exhibited this
phenotype (Table 1). Flies expressing Tau did not differ
from controls with respect to the infantile phenotype.
These phenotypes were Gal4-dose-dependent, because
they were more pronounced in males (which express more
Gal4) than in females (Table 1). Similar results were
obtained with the driver c155 (data not shown).
The increase in the number of adults exhibiting the infan-
tile phenotype indicates a synergistic interaction between
APPL and Tau overexpression at the genetic level. We
wondered whether the underlying cellular dysfunction
was related to vesicle transport because transfection of tau
in non-neuronal mammalian cells results in almost com-
plete suppression of organelle movement [4,5]. Moreover,
a phenotype resembling the infantile phenotype has pre-
viously been associated with neuroendocrine insufficiency
[20], which in this case could result from defects in trans-
port and/or secretion. Third instar larval peripheral nerves
were immunoreacted with antibodies against a synaptic
protein, Synaptotagmin. In wild-type larvae, the signal
was very low in abdominal nerves containing the motor
axons (Figure 1a) and was most intense at the neuro-
muscular junctions (data not shown). Indeed, abdominal
nerves of larvae overexpressing APPL showed a signifi-
cantly higher Synaptotagmin content, evidenced as an
enhanced diffused signal with numerous bright punctate
dots (Figure 1b), whereas expression of Tau resulted in
large accumulations of Synaptotagmin (Figure 1c). When
both APPL and Tau were overexpressed, the signal was
distinct from either APPL or Tau expression alone, as
both large accumulations and a higher frequency of bright
and larger punctate dots were observed (Figure 1d). 
We also analyzed the distribution of neuropeptide-contain-
ing dense core vesicles in larval peptidergic neurons. The
central nervous systems (CNSs) of larvae were immuno-
reacted with antibodies against the neuropeptides myosup-
pressin (DMS) and DPKQDFMRFamide [21]. Each
neuropeptide was expressed in a few cells in the larval
CNS [21]. When APPL and Tau were expressed together,
the signal for both peptides in the distal processes dramati-
cally decreased whereas somatic and proximal signals
remained the same (Figure 2). In CNSs overexpressing
APPL, we observed a slight but consistent reduction of
signal in axons at the ventral ganglion, whereas Tau
expression had only a minimal effect (data not shown).
Thus, the transport of both neuropeptide-containing dense
core vesicles and synaptic vesicles is disrupted.
These observations suggest that inhibition of microtubule-
associated transport, as in the case of Tau overexpression,
can be further compromised by overexpressing APPL.
The interaction observed between APPL and Tau,
although synergistic at the organismal phenotypic level,
could simply be additive at the transport level. It is worth
mentioning, though, that several groups have described a
direct physical interaction between APP and Tau [6,7], as
well as between APP and the cytoskeleton [22]. 
APPL overexpression shows genetic interaction with the
Kinesin heavy chain gene 
If APPL has a role in regulating vesicle transport, alter-
ations in other components of the vesicle transport
machinery should also enhance APPL-overexpression-
associated phenotypes in a similar way to the effect that
we have observed with Tau. One of these components is
the motor protein Kinesin. Kinesin heavy chain, a subunit
of the cytoplasmic motor encoded by the vital gene Khc, is
essential for synaptic vesicular transport [23]. We tested
the effect of a 50% reduction of Kinesin heavy chain, by
reducing the Khc gene dose, on the infantile phenotype
frequency. The viability of APPL-overexpressing adults
was only slightly affected by the decrease in Kinesin
heavy chain (ApplG1a;UAS–Appl Khc+/Khc– males showed
73% and 80% viability with Khc null alleles Khc8 and
Df(2R)JP6, respectively; viability was normalized with
respect to ApplG1a;UAS–Appl/+ males). Almost 90% of the
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Figure 1
Retention of the synaptic protein Synaptotagmin in larval motor axons.
(a) In wild-type larvae, Synaptotagmin was undetectable in abdominal
segmental nerves that contained larval motor axons. (b) In Df(1)w
ApplG1a;UAS–Appl/+ larvae, which overexpress APPL,
Synaptotagmin was retained in axons in small dot-like structures. (c) In
Df(1)w ApplG1a;UAS–tau57-3/+ larvae, which express Tau,
Synaptotagmin was retained in axons in large accumulations.
(d) Coexpression of APPL and Tau in Df(1)w ApplG1a;UAS–Appl
UAS–tau57-3/+ larvae resulted in higher retention of Synaptotagmin.
Third instar larval wall preparations were stained in parallel with
antibodies against Synaptotagmin [28] (a gift from H. Bellen) using
standard protocols [23]. Confocal images from segmental nerves in
abdominal segments A4–A5 were obtained using the same
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Table 1
Association of the infantile phenotype with neuronal Gal4-
driven overexpression of APPL and/or Tau.
Genotype Overexpression Infantile phenotype (%)
Females Males
ApplG1a/w/Y;+/+ None 0.6 (476) 0.0 (290)
ApplG1a/w/Y;UAS–Appl/+ APPL 1.4 (289) 6.8 (176)
ApplG1a/w/Y;UAS–tau57-3/+ Tau 0.2 (479) 0.5 (203)
ApplG1a/w/Y; APPL + Tau 36.2 (362) 99.3 (138)
UAS–Appl UAS–tau57-3/+
Df(1)w ApplG1a/Df(1)w ApplG1a females were crossed to
w/Y;UAS–*/SM6 males at 30°C, and progeny phenotypes analyzed.
Adults were scored as having the infantile phenotype if their wings
remained folded; this was usually accompanied by soft cuticle and
premature death. The figure shown is the percentage of flies with the
infantile phenotype from the total number of eclosing adults of that
genotype (indicated in brackets).
APPL-overexpressing males showed the infantile pheno-
type in a Khc–/Khc+ background, however, whereas only a
small percentage had this phenotype in a Khc+/Khc+ back-
ground (Table 2). The reduction in Kinesin heavy chain
was causal to this effect, as two different Khc null alleles
(Khc8 and Df(2R)JP6) gave the same result, and the pheno-
type was completely rescued by a transgene containing
the Khc+ genomic fragment (P(Khc+)) [10]. The effect was
also dependent on the amount of APPL protein, because
the phenotype was observed only in males (which express
more APPL) and not in females. 
A viable Khc allele [24] is one of the few mutations that
have been described as suppressors of the leg shaking
phenotype of the potassium channel mutant Shaker (Sh).
Because both APPL overexpression and Khc mutations
resulted in axonal retention of Synaptotagmin and showed
a genetic synergistic interaction, we tested whether APPL
overexpression could also suppress the leg shaking pheno-
type of Sh. Progeny from the cross Gal4 ShKS133 ×
UAS–Appl/CyO (Gal4 designates drivers ApplG1a or c155)
were etherized and the leg shaking behaviour of sibling
flies with (Gal4 ShKS133;UAS–Appl/+) and without
(Gal4 ShKS133;CyO/+) APPL overexpression was timed and
visually assessed (see Supplementary material published
with this article on the internet). At least 100 females and
50 males of each genotype were tested. In all cases, neu-
ronal APPL overexpression completely suppressed the
leg shaking phenotype of ShKS133. The suppression was
complete during the first three days and started to
decrease on the fourth day, a behaviour similar to that
described for Sh;Khc double mutants [24]. Older flies
exhibited the non-shaking phenotype for a short time
(2–3 minutes) immediately after anesthesia, after which
they started shaking at intervals.
Thus, alterations in axonal traffic caused by reduction of
Kinesin heavy chain are also enhanced by APPL overex-
pression. Moreover, APPL overexpression and mutations
in Khc show phenotypic similarities. In this regard it is
interesting to note that nerve injury causes increased
expression of several molecular motors [25] together with
increased synthesis and secretion of APP [26].
APPL function
In two backgrounds in which microtubule-associated trans-
port is compromised, APPL overexpression seemed to have
a synergistic effect at the organismal level, implying a
potential, direct or indirect, role for this protein in micro-
tubule-dependent vesicle trafficking. In the experimental
model used in this study, overexpression of APPL alone
caused a defect in vesicle trafficking as perceived in Synap-
totagmin retention in axons, but the specific step affected
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Figure 2
Neuropeptide immunoreactivity in larval brains. Larval brains were
stained with antibodies against (a,b) myosuppressin (DMS) [21] or
(c,d) DPKQDFMRFamide [21] neuropeptides (a gift from R. Nichols).
The genotypes are (a,c) wild type and (b,d) c155 w;UAS–Appl
UAS–tau57-3/+. Third instar larval brains were stained in parallel using
standard protocols [29]. The final image is a projection of confocal
images obtained using the same parameters for all genotypes. Cell
bodies (arrowheads) show similar levels of signal in all genotypes. The
immunoreactivity in distal processes (arrows), however, is dramatically
reduced when APPL and Tau are coexpressed (b,d). The asymmetry in
the brain cell soma in (b) is due to the rotated position of the left lobe.
Insets in (b,d) are higher magnification (2×) images of the boxed area
in the ventral ganglion, obtained with confocal settings that enhance
the signal (more laser and higher gain); notice the presence of distal
processes with positive neuropeptide immunoreactivity. The scale bar
in (d) represents 50 µm. Anterior is to the top.












Enhancement of the APPL-overexpression-related infantile
phenotype by reduction of Kinesin heavy chain.
Genotype Khc Infantile phenotype (%)
gene dosage Females Males
ApplG1a/w/Y;UAS–Appl/+ Two 1.2 (164) 3.8 (131)
ApplG1a/w/Y;UAS–Appl/Khc8 One 3.2 (221) 89.6 (106)
ApplG1a/w/Y;UAS–Appl/ One 1.5 (135) 84.7 (85)
Df(2R)JP6
ApplG1a/w/Y;UAS–Appl/ One + one 4.2 (214) 5.4 (92)
Df(2R)JP6;P(Khc+)/+ transgene
The number of flies with the infantile phenotype from the progeny of
cross Df(1)w ApplG1a/Df(1)w ApplG1a;UAS–Appl/SM6 ×
w/Y;Khc*/SM6 (at 30°C) was scored. Khc8 and Df(2R)JP6 are two
Khc null alleles [10]; P(Khc+) is a Khc+ genomic transgene on the
third chromosome [10]. The figure shown is the percentage of flies
with the infantile phenotype from the total number of eclosing adults of
that genotype (indicated in brackets).
in the intracellular trafficking network is not yet known.
APPL must function in a regulatory capacity, as loss-of-
function Appl– mutants are viable. APPL might act only in
response to particular stimuli, so that the lack of this protein
would result in only subtle phenotypes, such as the behav-
ioral deficits observed in Appl-null flies [11] and a modest
decrease in synaptic boutons at the neuromuscular junction
(M. Packard and V. Budnik, personal communication). 
Recent discoveries have shown that Familial Alzheimer’s
Disease is caused by mutations in the presenilin genes
and that Presenilin1 affects trafficking of membrane pro-
teins, and specifically of APP [27]. The proposed cellular
function of APPL in vesicle transport could provide mem-
brane trafficking as a common connection between APP
and Presenilins. 
Supplementary material
A supplementary figure showing that APPL overexpression sup-
presses the shaking phenotype of Shaker is published with this paper
on the internet.
Acknowledgements
We thank R. Nichols and H. Bellen for providing antibodies, B. Saxton and
K. Ito for fly stocks, and Xiaowu Zheng for technical support. This work was
supported by the National Institute of Health grant GM 22350. L.T. was sup-
ported by a postdoctoral fellowship from the Ministry of Education of Spain,
and I.K by an Undergraduate Research Award from Brandeis University. 
References
1. Sisodia SS, Price DL: Role of the beta-amyloid protein in
Alzheimer’s disease. FASEB J 1995, 9:366-370.
2. Mattson MP: Cellular actions of beta-amyloid precursor protein
and its soluble and fibrillogenic derivatives. Physiol Rev 1997,
77:1081-1132.
3. Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, et al.:
Altered microtubule organization in small-calibre axons of mice
lacking tau protein. Nature 1994, 369:488-491.
4. Sato-Harada R, Okabe S, Umeyama T, Kanai Y, Hirokawa N:
Microtubule-associated proteins regulate microtubule function as
the track for intracellular membrane organelle transports. Cell
Struct Funct 1996, 21:283-295.
5. Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow
E: Overexpression of tau protein inhibits kinesin-dependent
trafficking of vesicles, mitochondria, and endoplasmic reticulum:
implications for Alzheimer’s disease. J Cell Biol 1998, 143:777-794.
6. Smith MA, Siedlak SL, Richey PL, Mulvihill P, Ghiso J, Frangione B,
et al.: Tau protein directly interacts with the amyloid beta-protein
precursor: implications for Alzheimer’s disease. Nat Med 1995,
1:365-369.
7. Islam K, Levy E: Carboxyl-terminal fragments of beta-amyloid
precursor protein bind to microtubules and the associated
protein tau. Am J Pathol 1997, 151:265-271.
8. Greenberg SM, Koo EH, Selkoe DJ, Qiu WQ, Kosik KS: Secreted
beta-amyloid precursor protein stimulates mitogen-activated
protein kinase and enhances tau phosphorylation. Proc Natl Acad
Sci USA 1994, 91:7104-7108.
9. Busciglio J, Lorenzo A, Yeh J, Yankner BA: β-amyloid fibrils induce
tau phosphorylation and loss of microtubule binding. Neuron
1995, 14:879-888.
10. Saxton WM, Hicks J, Goldstein LS, Raff EC: Kinesin heavy chain is
essential for viability and neuromuscular functions in Drosophila,
but mutants show no defects in mitosis. Cell 1991, 64:1093-1102.
11. Luo L, Tully T, White K: Human amyloid precursor protein
ameliorates the behavioral deficits of flies deleted for Appl gene.
Neuron 1992, 9:595-605.
12. Müller U, Cristina N, Li Z, Wolfer DP, Lipp H, Rülicke T, et al.:
Behavioral and anatomical deficits in mice homozygous for a
modified β-amyloid precursor protein gene. Cell 1994, 79:755-765.
13. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R,
Smith DW, et al.: β-amyloid precursor protein-deficient mice show
reactive gliosis and decreased locomotor activity. Cell 1995,
81:525-531.
14. Bishop JM: Cellular oncogenes and retroviruses. Annu Rev
Biochem 1983, 52:301-354.
15. Lin DM, Goodman CS: Ectopic and increased expression of
Fasciclin II alters motoneuron growth cone guidance. Neuron
1994, 13:507-523.
16. Brand AH, Perrimon N: Targeted gene expression as a means of
altering cell fates and generating dominant phenotypes.
Development 1993, 118:401-415.
17. Rosen RR, Martin-Morris L, Luo L, White K: A Drosophila gene
encoding a protein resembling the human β-amyloid protein
precursor. Proc Natl Acad Sci USA 1989, 86:2478-2482.
18. Ito K, Sass H, Urban J, Hofbauer A, Schneuwly S: GAL4-responsive
UAS-tau as a tool for studying the anatomy and development of
the Drosophila central nervous system. Cell Tissue Res 1997,
290:1-10.
19. Wandosell F, Avila J: Microtubule-associated proteins present in
different developmental stages of Drosophila melanogaster.
J Cell Biochem 1987, 35:83-92.
20. McNabb SL, Baker JD, Agapite J, Steller H, Riddiford LM, Truman JW:
Disruption of a behavioral sequence by targeted death of
peptidergic neurons in Drosophila. Neuron 1997, 19:813-823.
21. Nichols R, McCormick J, Lim I: Multiple antigenic peptides
designed to structurally related Drosophila peptides. Peptides
1997, 18:41-45.
22. Allinquant B, Moya K, Bouillot C, Prochiantz A: Amyloid precursor
protein in cortical neurons: coexistence of two pools differentially
distributed in axons and dendrites and association with
cytoskeleton. J Neurosci 1994, 14:6842-6854.
23. Hurd DD, Saxton WM: Kinesin mutations cause motor neuron
disease phenotypes by disrupting fast axonal transport in
Drosophila. Genetics 1996, 144:1075-1085.
24. Hurd DD, Stern M, Saxton WM: Mutation of the axonal transport
motor Kinesin enhances paralytic and suppresses Shaker in
Drosophila. Genetics 1996, 142:195-204.
25. Su QN, Namikawa K, Toki H, Kiyama H: Differential display reveals
transcriptional up-regulation of the motor molecules for both
anterograde and retrograde axonal transport during nerve
regeneration. Eur J Neurosci 1997, 9:1542-1547.
26. Otsuka N, Tomonaga M, Ikeda K: Rapid appearance of beta-
amyloid precursor protein immunoreactivity in damaged axons
and reactive glial cells in rat brain following needle stab injury.
Brain Res 1991, 568:335-338.
27. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, Iwatsubo T,
et al.: Effects of PS1 deficiency on membrane protein trafficking in
neurons. Neuron 1998, 21:1213-1221.
28. Littleton JT, Bellen HJ, Perin MS: Expression of synaptotagmin in
Drosophila reveals transport and localization of synaptic vesicles
to the synapse. Development 1993, 118:1077-1088.
29. Torroja L, Luo L, White K: APPL, the Drosophila member of the
APP-family, exhibits differential trafficking and processing in CNS
neurons. J Neurosci 1996, 16:4638-4650.
492 Current Biology, Vol 9 No 9
Neuronal overexpression of APPL, the Drosophila homologue of
the amyloid precursor protein (APP), disrupts axonal transport
Laura Torroja, Hsin Chu, Irina Kotovsky and Kalpana White
Current Biology 26 April 1999, 9:489–492
S1Supplementary material
Figure S1
APPL overexpression suppressed the shaking phenotype of Shaker
(Sh). Sibling males with (c155 w ShKS133;UAS–Appl/+; right) and
without (c155 w ShKS133;CyO/+; left) APPL overexpression were
etherized and photographed together under the dissecting microscope
using long (1.5–2 second) exposures. Under these conditions, flies
that shake (left) appear blurred and out of focus [24]. Progeny from the
cross Gal4 ShKS133 × UAS–Appl/CyO or Gal4 ShKS133 ×
UAS–Appl/UAS–Appl (reared at 30°C) were etherized, and the leg
shaking behaviour of flies was timed and visually assessed. Similar
behaviour was observed in all APPL-overexpressing genotypes, using
two panneural Gal4 lines (c155 and ApplG1a) and two UAS–Appl
lines (UAS–Appla and UAS–Applh). At least 100 females and 50
males of each genotype were tested (but only 12
w Sh c155;UAS–Applh/+ males, because this specific
Gal4/UAS–Appl combination is semilethal). 
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